Weil Reps Equity Firm In $294M Radiology Co. Purchase
The definitive agreement, announced Monday, calls for Providence Equity to offer vRad's stockholders $17.24 per share in cash. That figure is a 41.7 percent premium over the company's 30-day average closing price of $12.18 and a 54.9 percent premium over its three-month average of $11.3.
The companies have estimated the deal's value at $294 million.
VRad's board of directors has...
To view the full article, register now.